John B. Hiebert

662 total citations
23 papers, 483 citations indexed

About

John B. Hiebert is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, John B. Hiebert has authored 23 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Cardiology and Cardiovascular Medicine and 5 papers in Epidemiology. Recurrent topics in John B. Hiebert's work include Cardiovascular Function and Risk Factors (7 papers), Coenzyme Q10 studies and effects (6 papers) and Heart Failure Treatment and Management (6 papers). John B. Hiebert is often cited by papers focused on Cardiovascular Function and Risk Factors (7 papers), Coenzyme Q10 studies and effects (6 papers) and Heart Failure Treatment and Management (6 papers). John B. Hiebert collaborates with scholars based in United States, Canada and China. John B. Hiebert's co-authors include Janet D. Pierce, Qiuhua Shen, Amanda R. Thimmesch, James L. Vacek, Richard L. Clancy, Francisco J. Díaz, Francis Vella, J. Thomas Pierce, Milton T. Edgerton and George T. Rodeheaver and has published in prestigious journals such as Critical Care Medicine, The American Journal of Cardiology and Journal of Advanced Nursing.

In The Last Decade

John B. Hiebert

22 papers receiving 474 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John B. Hiebert United States 12 215 166 111 77 42 23 483
Amanda R. Thimmesch United States 11 244 1.1× 176 1.1× 105 0.9× 43 0.6× 49 1.2× 22 567
Luís Ramos Spain 15 187 0.9× 278 1.7× 216 1.9× 29 0.4× 41 1.0× 46 645
Katie Wiggins‐Dohlvik United States 8 111 0.5× 123 0.7× 63 0.6× 21 0.3× 47 1.1× 15 380
Meifen Shen China 11 173 0.8× 211 1.3× 78 0.7× 34 0.4× 54 1.3× 25 499
Hao Qian China 15 252 1.2× 113 0.7× 166 1.5× 88 1.1× 52 1.2× 33 675
Darius Kubulus Germany 17 234 1.1× 52 0.3× 94 0.8× 28 0.4× 66 1.6× 27 591
Vladimír Nosáľ Slovakia 10 68 0.3× 148 0.9× 153 1.4× 59 0.8× 30 0.7× 33 401
Julie Sweet United States 13 81 0.4× 116 0.7× 179 1.6× 52 0.7× 82 2.0× 16 509
Y. Z. Qian United States 8 179 0.8× 56 0.3× 35 0.3× 67 0.9× 59 1.4× 9 468
Marta Skowrońska Poland 12 150 0.7× 65 0.4× 154 1.4× 82 1.1× 87 2.1× 34 551

Countries citing papers authored by John B. Hiebert

Since Specialization
Citations

This map shows the geographic impact of John B. Hiebert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John B. Hiebert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John B. Hiebert more than expected).

Fields of papers citing papers by John B. Hiebert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John B. Hiebert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John B. Hiebert. The network helps show where John B. Hiebert may publish in the future.

Co-authorship network of co-authors of John B. Hiebert

This figure shows the co-authorship network connecting the top 25 collaborators of John B. Hiebert. A scholar is included among the top collaborators of John B. Hiebert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John B. Hiebert. John B. Hiebert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pierce, Janet D., Qiuhua Shen, Francisco J. Díaz, et al.. (2022). Effects of Ubiquinol and/or D-ribose in Patients With Heart Failure With Preserved Ejection Fraction. The American Journal of Cardiology. 176. 79–88. 11 indexed citations
2.
Shen, Qiuhua, et al.. (2021). Clinical trial visits in the age of COVID-19: implementation of research participant safety measures. International Journal of Clinical Trials. 8(2). 167–167. 5 indexed citations
3.
Shen, Qiuhua, et al.. (2021). Mitochondrial bioenergetics and D-ribose in HFpEF: a brief narrative review. Annals of Translational Medicine. 9(19). 1504–1504. 7 indexed citations
4.
Pierce, Janet D., et al.. (2020). Potential use of ubiquinol and d-ribose in patients with heart failure with preserved ejection fraction. Annals of Medicine and Surgery. 55. 77–80. 4 indexed citations
5.
Shen, Qiuhua, John B. Hiebert, & Janet D. Pierce. (2020). Underlying Causes of High Output Heart Failure. 1–4. 1 indexed citations
6.
Hiebert, John B., et al.. (2019). Use of speckle tracking to assess heart failure with preserved ejection fraction. Journal of Cardiology. 74(5). 397–402. 23 indexed citations
7.
Pierce, Janet D., John B. Hiebert, Qiuhua Shen, et al.. (2019). Development of a point-of-contact technique to measure adenosine triphosphate: A quality improvement study. Annals of Medicine and Surgery. 41. 29–32. 2 indexed citations
8.
Hiebert, John B., Amanda R. Thimmesch, J. Thomas Pierce, et al.. (2018). Understanding D-Ribose and Mitochondrial Function. PubMed. 6(1). 1–1. 38 indexed citations
9.
Pierce, Janet D., John B. Hiebert, Amanda R. Thimmesch, et al.. (2018). Study protocol, randomized controlled trial: reducing symptom burden in patients with heart failure with preserved ejection fraction using ubiquinol and/or D-ribose. BMC Cardiovascular Disorders. 18(1). 57–57. 23 indexed citations
10.
Pierce, Janet D., Raeesa Gupte, Amanda R. Thimmesch, et al.. (2018). Ubiquinol treatment for TBI in male rats: Effects on mitochondrial integrity, injury severity, and neurometabolism. Journal of Neuroscience Research. 96(6). 1080–1092. 20 indexed citations
11.
Pierce, Janet D., Qiuhua Shen, Jill Peltzer, Amanda R. Thimmesch, & John B. Hiebert. (2017). A pilot study exploring the effects of ubiquinol on brain genomics after traumatic brain injury. Nursing Outlook. 65(5). S44–S52. 8 indexed citations
12.
Hiebert, John B., Qiuhua Shen, Amanda R. Thimmesch, & Janet D. Pierce. (2016). Impaired Myocardial Bioenergetics in HFpEF and the Role of Antioxidants. The Open Cardiovascular Medicine Journal. 10(1). 158–162. 10 indexed citations
13.
Shen, Qiuhua, et al.. (2016). Systematic Review of Traumatic Brain Injury and the Impact of Antioxidant Therapy on Clinical Outcomes. Worldviews on Evidence-Based Nursing. 13(5). 380–389. 44 indexed citations
14.
Hiebert, John B., Qiuhua Shen, Amanda R. Thimmesch, & Janet D. Pierce. (2015). Traumatic Brain Injury and Mitochondrial Dysfunction. The American Journal of the Medical Sciences. 350(2). 132–138. 185 indexed citations
15.
Shen, Qiuhua, et al.. (2014). Myocardial energetics and ubiquinol in diastolic heart failure. Nursing and Health Sciences. 16(4). 428–433. 13 indexed citations
16.
Shen, Qiuhua, et al.. (2012). Mitochondrial health – essential information for nurses. Journal of Nursing Education and Practice. 2(2). 2 indexed citations
17.
Shen, Qiuhua, John B. Hiebert, J. Thomas Pierce, Richard L. Clancy, & Janet D. Pierce. (2012). 550. Critical Care Medicine. 40. 1–328. 1 indexed citations
18.
Edlich, Richard F., et al.. (1978). Modification of the american burn association injury severity grading system. Journal of the American College of Emergency Physicians. 7(6). 226–228. 13 indexed citations
19.
Edlich, Richard F., George T. Rodeheaver, Michael D. Spengler, John B. Hiebert, & Milton T. Edgerton. (1977). Practical Bacteriologic Monitoring of the Burn Victim. Clinics in Plastic Surgery. 4(4). 561–569. 17 indexed citations
20.
Vella, Francis, et al.. (1972). Hemoglobin deer lodge: α2β2 2 His → Arg. Clinical Biochemistry. 5(1-4). 46–50. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amanda R. Thimmesch Breakdown of academic impact, for papers by Luís Ramos Breakdown of academic impact, for papers by Katie Wiggins‐Dohlvik Breakdown of academic impact, for papers by Meifen Shen Breakdown of academic impact, for papers by Hao Qian Breakdown of academic impact, for papers by Darius Kubulus Breakdown of academic impact, for papers by Vladimír Nosáľ Breakdown of academic impact, for papers by Julie Sweet Breakdown of academic impact, for papers by Y. Z. Qian Breakdown of academic impact, for papers by Marta Skowrońska
Rankless by CCL
2026